BAALC and ERG expression in acute myeloid leukemia with normal karyotype: Impact on prognosis

International Journal of Laboratory Hematology

Volumn 32, Issue 2, 2010, Pages 197-205

  Eid, M A ^a   Attia, M ^a   Abdou, S ^a   El Shazly, S F ^a   Elahwal, L ^a   Farrag, W ^a   Mahmoud, L ^a  

^a TANTA UNIVERSITY   (Egypt)

Author keywords

Acute myeloid leukemia; BAALC; ETS related gene; Prognostic impact and real time RT PCR

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BAALC GENE; BONE MARROW EXAMINATION; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DISEASE ASSOCIATION; ERG GENE; FEMALE; FOLLOW UP; GENE; GENE EXPRESSION; HUMAN; KARYOTYPE; LEUKOCYTE COUNT; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; MALE; NEOPLASM PROTEINS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS;

EID: 77953599675     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2009.01168.x     Document Type: Article

References (20)

1. Aviva P. & Caroline S. (2005) Glossary of terms. In: Medical Statistics at a Glance (ed. K. Moore), 2nd edn, pp. 144-152. Blackwell Publishing Ltd, Oxford, Appendix D.
2. Baldus C.D., Tanner S.M., Kusewitt D.F., Liyanarachchi S., Choi C., Caligiuri M.A., Bloomfield C.D. & Cgapelle A.L. (2003) BAALC, a novel marker of human hematopoiesis progenitor cells. Experimental Hematology 31, 1051-1056.
3. Baldus C.D., Liyanarchchi S., Mró zek K., Auer H., Tanner S.M., Guimond M., Ruppert A.S., Mohamed N., Davuluri R.V., Caligiuri M.A., Bloomfield C.D. & de la Chapelle A. (2004) Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: amplification discloses overexpression of APP, ETS2 and ERG genes. Proceedings of the National Academy of Sciences of the United States of America 101, 3915-3920.
4. Baldus C.D., Burmeister T., Martus P., Schwartz S., Gokbudget N., Bloomfield C.D., Hoelzer D., Theil E. & Hofmann W.K. (2006a) High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults. Journal of Clinical Oncology 24, 4714-4720.
5. Baldus C.D., Thiede C., Soucek S., Bloomfield C.D., Thiel E. & Ehninger G. (2006b) BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications. Journal of Clinical Oncology 24, 790-797.
6. Bienz M., Ludwig M., Mueller B.U., Leibundgut E.O., Ratschiller D., Solenthanler M., Fey M.F. & Pabst T. (2005) Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Clinical Cancer Research 11, 1416-1424.
7. Bullinger L., Döhner K., Bair E., Fröhling S., Schlenk R.F., Tibshirani R., Döhner H. & Pollack J.R. (2004) Use of gene expression profiling to identify prognostic subclasses in adult acute myeloidleukemia. New England Journal of Medicine 350, 1605-1616.
8. Cheson B.D., Cassileth P.A., Head D.R., Schiffer C.A., Bennett J.M., Bloomfield C.D., Brunning R., Gale R.P., Grever M.R. & Keating M.J. (1990) Report of the National Cancer Institute and sponsored workshop on definitions of diagnosis and response of acute myeloid leukemia. Journal of Clinical Oncology 8, 813-819.
9. Downing J.R. (2001) AML1/CBFβ transcription complex: its role in normal hematopoiesis and leukemia. Leukemia 15, 664-665.
10. Estey E.H. (2001) Therapeutic options for acute myelogenous leukemia. Cancer 92, 1059-1073.
11. Fröhling S., Schlenk R.F., Stolze I., Bihlmayr J., Benner A., Kreitmeier S., Tobis K., Döhner H. & Döhner K. (2004) CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. Journal of Clinical Oncology 22, 624-633.
12. Kottaridis P.D., Gale R.E., Frew M.E., Harrison G., Langabeer S.E., Belton A.A., Walker H., Wheatley K., Bowen D.T., Burnett A.K., Goldstone A.H. & Linch D.C. (2001) The presence of FLT3 internal tandem duplication in patients with acute myeloid leukemia adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United kingdom Medical Research Council AML 10 and 12 trials. Blood 98:1752-1759.
13. Marcocci G., Mrozek K. & Bloomfield C.D. (2005) Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics. Current Opinion in Hematology 12, 68-75.
14. Marcucci G., Baldus C.D., Ruppert A.S., Radmacher M.D., Mró zek K., Whitman S.P., Kolitz J.E., Edwards C.G., Vardiman J.W., Powell B.L., Baer M.R., Moore J.O., Perrotti D., Caligiuri M.A., Carroll A.J., Larson R.A., de la Chapelle A. & Bloomfield C.D. (2005) Overexpression of ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study. Journal of Clinical Oncology 23, 9234-9242.
15. Mrozek K., Marcucci G., Paschka P., Whitman S.P. & Bloomfield C.D. (2007) Clinical prevalence of mutations and gene expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 109, 431-448.
16. Oikawa T. (2004) ETS transcription factors: possible targets for cancer therapy. Cancer Science 95, 626-633.
17. Rainis L., Toki T., Pimanda J.E., Rosenthal E., Machol K., Strehl S., Gottgens B., Ito E. & Izraeli S. (2005) The protooncogene ERG in megakaryoblastic leukemias. Cancer Research 65, 7596-7602.
18. Scheijen B. & Griffin J.D. (2002) Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease. Oncogene 21, 3314-3333.
19. Tanner S.M., Austin J.L., Leone G., Rush L.J., Plass C., Heinonen K., Mró zek K., Sill H., Knuutila S., Kolitz J.E., Archer K.J., Caligiuri M.A., Bloomfield C.D. & de La Chapelle A. (2001) BAAL, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proceedings of the National Academy of Sciences of the United States of America 98, 13901-13906.
20. Valk P.J., Verhaak R.G., Beijen M.A., Erpelinck C.A., Barjesteh van Waalwijk van Doorn-Khosrovani S., Boer J.M., Beverloo H.B., Moorhouse M.J., van der Spek P.J., Löwenberg B. & Delwel R. (2004) Prognostically useful geneexpression profiles in acute myeloid leukemia. New England Journal of Medicine 350, 1617-1628.